Clinical Trial Update: A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether cell-free tumor DNA testing can guide the timing of initiating routine treatment for HPV-associated oropharyngeal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Oropharyngeal Squamous Cell Carcinoma
• Oropharyngeal Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: HPV, Oropharynx Cancer | Phase 2 | Status: RECRUITING